180 related articles for article (PubMed ID: 8492761)
1. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.
Leichner PK; Kwok CS
Med Phys; 1993; 20(2 Pt 2):529-34. PubMed ID: 8492761
[TBL] [Abstract][Full Text] [Related]
2. [Dosimetry and radiation dose distribution in tumors for radioimmunotherapy: the effect of tumor size].
Fujimori K; Furudate M
Kaku Igaku; 1994 Mar; 31(3):241-8. PubMed ID: 8176862
[TBL] [Abstract][Full Text] [Related]
3. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations.
Yorke ED; Williams LE; Demidecki AJ; Heidorn DB; Roberson PL; Wessels BW
Med Phys; 1993; 20(2 Pt 2):543-50. PubMed ID: 8492763
[TBL] [Abstract][Full Text] [Related]
4. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.
Bao A; Zhao X; Phillips WT; Woolley FR; Otto RA; Goins B; Hevezi JM
Med Phys; 2005 Jan; 32(1):200-8. PubMed ID: 15719971
[TBL] [Abstract][Full Text] [Related]
5. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
6. Experimental radioimmunotherapy.
Buchsbaum DJ; Langmuir VK; Wessels BW
Med Phys; 1993; 20(2 Pt 2):551-67. PubMed ID: 8492764
[TBL] [Abstract][Full Text] [Related]
7. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
Bardiès M; Chatal JF
Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of solid tumors.
Meredith RF; Johnson TK; Plott G; Macey DJ; Vessella RL; Wilson LA; Breitz HB; Williams LE
Med Phys; 1993; 20(2 Pt 2):583-92. PubMed ID: 8492767
[TBL] [Abstract][Full Text] [Related]
9. A unified approach to photon and beta particle dosimetry.
Leichner PK
J Nucl Med; 1994 Oct; 35(10):1721-9. PubMed ID: 7931677
[TBL] [Abstract][Full Text] [Related]
10. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
Dewaraja YK; Schipper MJ; Roberson PL; Wilderman SJ; Amro H; Regan DD; Koral KF; Kaminski MS; Avram AM
J Nucl Med; 2010 Jul; 51(7):1155-62. PubMed ID: 20554734
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.
D'Arienzo M; Cicone F; Chiacchiararelli L; Coniglio A; Delaloye AB; Scopinaro F
Cancer Biother Radiopharm; 2012 Mar; 27(2):124-33. PubMed ID: 22283680
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy dosimetry--a review.
Strand SE; Jönsson BA; Ljungberg M; Tennvall J
Acta Oncol; 1993; 32(7-8):807-17. PubMed ID: 8305230
[TBL] [Abstract][Full Text] [Related]
13. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4.
Strigari L; Menghi E; D'Andrea M; Benassi M
Med Phys; 2006 Sep; 33(9):3383-9. PubMed ID: 17022234
[TBL] [Abstract][Full Text] [Related]
15. [Calculation algorithm of three-dimensional absorbed dose distribution due to in vivo administration of nuclides for radiotherapy].
Uchida I; Yamada Y; Oyamada H; Nomura E
Kaku Igaku; 1992 Nov; 29(11):1299-306. PubMed ID: 1484421
[TBL] [Abstract][Full Text] [Related]
16. Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.
Hindorf C; Lindén O; Stenberg L; Tennvall J; Strand SE
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):4003S-6S. PubMed ID: 14506200
[TBL] [Abstract][Full Text] [Related]
17. A voxel-dose algorithm of heterogeneous activity distribution for Monte-Carlo simulation of radionuclide therapy dosimetry.
Lin H; Jing J; Cai J; Xu L
Cancer Biother Radiopharm; 2012 Aug; 27(6):344-52. PubMed ID: 22804457
[TBL] [Abstract][Full Text] [Related]
18. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
[TBL] [Abstract][Full Text] [Related]
20. High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
Rajendran JG; Fisher DR; Gopal AK; Durack LD; Press OW; Eary JF
J Nucl Med; 2004 Jun; 45(6):1059-64. PubMed ID: 15181141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]